Our investors
In 2024, Adcendo completed a Series B financing round through an international syndicate of leading life science and biotech investors from both EU and US, raising $135 million to advance, broaden, and accelerate the development of our first-in-class ADC pipeline.
Including our series A financing round and extensions, the Company has raised a total of $240 million to date
TCGX
Founded in 2021, TCGX partners with intrepid innovators who can translate cutting-edge science into products that will make a meaningful difference for patients. TCGX manages ~$2 billion in capital and operates offices in San Francisco, Palo Alto, and New York City.
Visit www.tcgcrossover.com
Orbimed Advisors
OrbiMed is a leading healthcare investment firm, with approximately $17 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 130 professionals is based in New York City, San Francisco, London, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.
Visit www.orbimed.com
Surveyor Capital Management
Surveyor Capital Management is a global investment firm established in 2008 as part of Citadel. Specializing in long-term fundamental equity strategies, the firm employs deep research and sector-focused teams to identify investment opportunities. With approximately 190 professionals across major U.S. cities, Surveyor emphasizes rigorous risk controls and multi-factor hedging. The firm has made over 116 investments, showcasing its commitment to building strong relationships with company management teams. Known for its disciplined approach, Surveyor Capital Management aims to deliver superior returns while managing risk effectively.
RA Capital Management
RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond.
Visit www.racap.com
Pontifax Venture Capital
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management. We seek transformative, cutting-edge life sciences technologies at all development stages. Our portfolio comprises of about 100 companies that develop breakthrough solutions to substantial unmet needs.
Visit www.pontifax.com
HealthCap
HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe. Since the start in 1996, HealthCap has backed and built more than 100 companies. HealthCap’s investment strategy focuses on diseases with high unmet medical needs and breakthrough therapies which have the potential to be transformative and improve the lives of patients suffering from these conditions
Visit www.healthcap.eu
Ysios Capital
Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over 400M EUR through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies
Visit www.ysioscapital.com
TPG Life Sciences Innovations (LSI)
TPG Life Sciences Innovations (LSI) seeks to partner with companies developing disruptive science, technologies, and business models to meaningfully improve outcomes in patients with significant unmet medical needs. Our investment team leverages deep scientific, clinical, and operational expertise, as well as our investment experience across multiple therapeutic areas and modalities. We invest thematically, with a focus on areas such as oncology, autoimmune and inflammatory diseases, cardiometabolic diseases, ophthalmology, rare diseases, as well as commercial stage medical devices and tech-enabled services.
Visit www.tpg.com
Venrock Healthcare Capital Partners
Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies have included 10X Genomics, AveXis, Gilead Sciences, Idec Pharma, Illumina, Millennium Pharma and RayzeBio.
Visit www.venrock.com
Logos Capital
Logos Capital is a San Francisco-based investment firm founded in 2011, specializing in impact investing within biotechnology and sustainable technologies. Combining venture capital and private equity, the firm supports socially responsible companies that address global challenges. With a team of over 55 professionals, Logos Capital emphasizes high ethical standards and deep technical expertise, particularly in blockchain. The firm actively tracks its investments’ contributions to sustainability and seeks to create a positive impact on communities.
Visit www.logoscapital.com
Novo Holdings
Novo Holdings is recognized as a world-leading life science investor with a focus on creating long-term value. As a life sciences investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio of diversified financial assets
Visit www.novoholdings.dk
Dawn Biopharma
Biopharma platform backed by KKR to support companies committed to the development of innovative medicines. Focused on therapeutics and investing globally.
Visit Dawn Biopharmas LinkedIn
Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in therapeutics, medtech and digital health, based in Europe and North America.
Visit www.gildehealthcare.com